These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25545662)

  • 1. Incidence of Positive Ventricular Late Potentials Differs in Postural Changes among Supine, Left, and Right Lateral Decubitus, and Prone and Sitting Positions in Brugada Syndrome.
    Yoshioka K; Amino M; Nakamura M; Kanda S; Kobayashi Y; Ikari Y; Shima M; Tanabe T
    Ann Noninvasive Electrocardiol; 2015 Sep; 20(5):488-97. PubMed ID: 25545662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac electrophysiological substrate underlying the ECG phenotype and electrogram abnormalities in Brugada syndrome patients.
    Zhang J; Sacher F; Hoffmayer K; O'Hara T; Strom M; Cuculich P; Silva J; Cooper D; Faddis M; Hocini M; Haïssaguerre M; Scheinman M; Rudy Y
    Circulation; 2015 Jun; 131(22):1950-9. PubMed ID: 25810336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of high-risk Brugada syndrome patients by combined analysis of late potential and T-wave amplitude variability on ambulatory electrocardiograms.
    Yoshioka K; Amino M; Zareba W; Shima M; Matsuzaki A; Fujii T; Kanda S; Deguchi Y; Kobayashi Y; Ikari Y; Kodama I; Tanabe T
    Circ J; 2013; 77(3):610-8. PubMed ID: 23439592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of late potentials for 24 hours between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy using a novel signal-averaging system based on Holter ECG.
    Abe A; Kobayashi K; Yuzawa H; Sato H; Fukunaga S; Fujino T; Okano Y; Yamazaki J; Miwa Y; Yoshino H; Ikeda T
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):789-95. PubMed ID: 22665699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of 12-lead and signal-averaged Holter electrocardiograms after pilsicainide provocation for risk stratification in Brugada syndrome.
    Kakihara J; Takagi M; Hayashi Y; Tatsumi H; Doi A; Yoshiyama M
    Heart Vessels; 2017 Sep; 32(9):1151-1159. PubMed ID: 28364267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between ST-segment morphology and conduction disturbances detected by signal-averaged electrocardiography in Brugada syndrome.
    Takami M; Ikeda T; Enjoji Y; Sugi K
    Ann Noninvasive Electrocardiol; 2003 Jan; 8(1):30-6. PubMed ID: 12848811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brugada syndrome in children.
    Crosson JE; Nies M
    Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):173-81. PubMed ID: 25583159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: Potential diagnostic and prognostic implications.
    Gray B; Kirby A; Kabunga P; Freedman SB; Yeates L; Kanthan A; Medi C; Keech A; Semsarian C; Sy RW
    Heart Rhythm; 2017 Jun; 14(6):866-874. PubMed ID: 28528724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations.
    Morita H; Zipes DP; Wu J
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S34-43. PubMed ID: 19880072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Posture-induced intraocular pressure measurements].
    Zhen Y; Wang H; Hao J; Ding J; Wang N
    Zhonghua Yan Ke Za Zhi; 2014 May; 50(5):333-7. PubMed ID: 25052801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms Underlying Epicardial Radiofrequency Ablation to Suppress Arrhythmogenesis in Experimental Models of Brugada Syndrome.
    Patocskai B; Yoon N; Antzelevitch C
    JACC Clin Electrophysiol; 2017 Apr; 3(4):353-363. PubMed ID: 28948234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of ventricular late potentials and intradialytic changes in serum electrolytes, ultrafiltration, left ventricular ejection fraction and left ventricular mass index in haemodialysis patients.
    Dubrava J; Fekete J; Lehotska A
    Bratisl Lek Listy; 2003; 104(12):388-92. PubMed ID: 15053330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different sleeping postures on intraocular pressure and ocular perfusion pressure in healthy young subjects.
    Lee TE; Yoo C; Kim YY
    Ophthalmology; 2013 Aug; 120(8):1565-70. PubMed ID: 23561328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical utility of procainamide-induced late potentials on the signal averaged ECG.
    Pearman CM; Walia J; Alqarawi W; Larsen JM; Leach E; Krahn AD; Laksman Z
    Pacing Clin Electrophysiol; 2021 Dec; 44(12):2046-2053. PubMed ID: 34648655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study.
    Postema PG; van Dessel PF; de Bakker JM; Dekker LR; Linnenbank AC; Hoogendijk MG; Coronel R; Tijssen JG; Wilde AA; Tan HL
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):379-86. PubMed ID: 19808433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effect of 5 recumbent positions on autonomic nervous modulation in patients with coronary artery disease.
    Yang JL; Chen GY; Kuo CD
    Circ J; 2008 Jun; 72(6):902-8. PubMed ID: 18503214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.